In one paragraphArticle in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Siva Hariprasad KurmaInstitute of Organic Chemistry and Technology, Faculty of Chemical Technology, University of Pardubice, Studentska 573, 532 10 Pardubice, Czech Republic.ORCID 0000-0002-6597-192X Camila Adarvez-FeresinInstituto Multidisciplinario de Investigaciones Biológicas (IMIBIO-SL), Facultad de Química, Bioquímica y Farmacia, Universidad Nacional de San Luis, Chacabuco 915, San Luis 5700, Argentina.ORCID 0000-0003-4308-9706 Oscar ParraviciniInstituto Multidisciplinario de Investigaciones Biológicas (IMIBIO-SL), Facultad de Química, Bioquímica y Farmacia, Universidad Nacional de San Luis, Chacabuco 915, San Luis 5700, Argentina.
Adriana GarroInstituto Multidisciplinario de Investigaciones Biológicas (IMIBIO-SL), Facultad de Química, Bioquímica y Farmacia, Universidad Nacional de San Luis, Chacabuco 915, San Luis 5700, Argentina.
Sarka StepankovaDepartment of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Studentska 573, 532 10 Pardubice, Czech Republic.ORCID 0000-0002-1969-5258 Jan HosekDepartment of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, 621 00 Brno, Czech Republic.ORCID 0000-0003-0975-1671 Karel PaukInstitute of Organic Chemistry and Technology, Faculty of Chemical Technology, University of Pardubice, Studentska 573, 532 10 Pardubice, Czech Republic.
Jovana LisicicDepartment of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, 621 00 Brno, Czech Republic.
Josef JampilekDepartment of Chemical Biology, Faculty of Science, Palacky University Olomouc, Slechtitelu 27, 779 00 Olomouc, Czech Republic.ORCID 0000-0003-2003-9052 Ricardo Daniel EnrizInstituto Multidisciplinario de Investigaciones Biológicas (IMIBIO-SL), Facultad de Química, Bioquímica y Farmacia, Universidad Nacional de San Luis, Chacabuco 915, San Luis 5700, Argentina.
Ales ImramovskyInstitute of Organic Chemistry and Technology, Faculty of Chemical Technology, University of Pardubice, Studentska 573, 532 10 Pardubice, Czech Republic.ORCID 0000-0001-9476-9627 Funding
Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET)Ministry of Agriculture DKRVO RO0523National University of San LuisSlovak Research and Development Agency APVV-24-0341
6 · The paper itselfAbstract
In the present work, a novel series of eleven sulfonate derivatives with potent inhibitory activity against butyrylcholinesterase (BChE) is reported. Of these, compounds 2-[(
Indexed as
Anti-Inflammatory AgentsButyrylcholinesteraseCholinesterase InhibitorsDrug DesignSulfonic AcidsAnimalsHumansMolecular Docking SimulationMolecular Dynamics SimulationStructure-Activity RelationshipAnti-Inflammatory AgentsButyrylcholinesteraseCholinesterase InhibitorsSulfonic AcidsAlzheimer’s diseaseanti-inflammatory activityBChE activitymolecular modelingQTAIM calculationssulfonate derivatives
Identifiers
PMID41977297
PMCPMC13072879
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390